Spring House, PA, United States of America

Kristen Picha

USPTO Granted Patents = 14 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 79(Granted Patents)

Location History:

Radnor, PA (US) (2010 - 2013)
Spring House, PA (US) (2014 - 2017)
Malvern, PA (US) (2010 - 2021)

Company Filing History:

9 out of 410

Janssen Biotech, Inc.

2 out of 832,680

Other

patents

Years Active: 2010-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12304939 - EGFR and C-met fibronectin type III domain binding molecules (2025-05-20),

2. 10954284 - EGFR and c-Met fibronectin type III domain binding molecules (2021-03-23),

3. 10662235 - Cysteine engineered fibronectin type III domain binding molecules (2020-05-26),

4. 9725497 - EGFR and C-Met fibronectin type III domain binding molecules (2017-08-08),

5. 9695228 - EGFR and c-Met fibronectin type III domain binding molecules (2017-07-04),

6. 8906649 - Antibodies binding human collagen II (2014-12-09),

7. 8883447 - Anti-GLP-1R antibodies and their uses (2014-11-11),

8. 8394378 - Antibodies binding human collagen II (2013-03-12),

9. 8389689 - Anti-GLP-1R antibodies and their uses (2013-03-05),

10. 8153583 - Toll like receptor 3 antagonists, methods and uses (2012-04-10),

11. 8071103 - Pharmaceutical composition comprising a human GLP-1 mimetibody (2011-12-06),

12. 8043616 - sRAGE mimetibody, compositions, methods and uses (2011-10-25),

13. 7833531 - Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists (2010-11-16),

14. 7812121 - GLP-2 mimetibodies, polypeptides, compositions, methods and uses (2010-10-12),

Title: Kristen Picha: Innovator in Therapeutic Molecules

Introduction

Kristen Picha is a prominent inventor based in Spring House, PA (US), known for her significant contributions to the field of therapeutic molecules. With a total of 14 patents to her name, she has made remarkable strides in the development of innovative solutions for the treatment and diagnosis of various diseases and disorders.

Latest Patents

Her latest patents include the development of EGFR and c-Met fibronectin type III domain binding molecules. These patents focus on monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding these molecules, vectors, host cells, and methods of making them. These innovations are crucial for generating therapeutic molecules that can effectively treat and diagnose a range of medical conditions.

Career Highlights

Throughout her career, Kristen has worked with notable companies such as Janssen Biotech, Inc. and Centocor, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking advancements in biotechnology.

Collaborations

Kristen has collaborated with talented individuals in her field, including Karyn O'Neil and Ricardo Attar. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kristen Picha's work in the field of therapeutic molecules exemplifies her dedication to advancing medical science. Her numerous patents and collaborations highlight her role as a leading inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.